collections

The AACR Annual Meeting is where new modalities and targets debut, each April.

AACR Project GENIE is real-world tumour sequencing data shared by leading cancer centres.

Hope Lodge gives patients and a caregiver a free place to stay near the hospital when treatment is far from home.

Road To Recovery is the American Cancer Society's free volunteer driving service for getting to treatment appointments.

ADC Review covers everything ADC: deals, payload chemistry, and monthly pipeline summaries.

ADCdb and ADC Review are where to track the hundreds of ADCs in trials, with target, payload, and linker.

A childhood-cancer charity started by a four-year-old patient's lemonade stand that now funds hundreds of grants and runs an open-science data lab for paediatric cancer genomics.

America's answer to UK Biobank, built for diversity.

The American Cancer Society is the largest US cancer charity. It publishes the annual US cancer statistics that most news reports quote, screening recommendations that differ from the US Preventive Services Task Force in places (colorectal screening from 45, for example), and plain-language patient guides for every cancer.

The American Cancer Society answers 1-800-227-2345 every hour of every day, free, and can connect callers to its free rides and lodging programmes.

Arc's growing library of cell data, the fuel for virtual cell models.

ASCO guidelines are the American oncology society's guidelines, strongest on supportive care, survivorship, biomarker testing and resource-stratified recommendations for lower-income settings, complementing NCCN's algorithms.

ASCO Daily News is the American Society of Clinical Oncology's free news service, published daily during meetings and weekly otherwise, covering sessions as they happen and guideline updates. It is most useful during the Annual Meeting, when it adds expert perspective to the abstracts.

The primary record of what was presented at ASCO meetings each year.

The ASH Annual Meeting is December's blood-cancer summit, bringing CAR-T, bispecifics, menin, BTK, and myeloma news.

The ASTRO Annual Meeting is where hypofractionation, SBRT, protons, FLASH, and MR-guided radiotherapy results appear.

Australians are invited to free bowel, breast and cervical screening by age, and since 2025 to lung screening if they have a heavy smoking history.

A GitHub list of every cancer variant database, maintained by the community.

Be Part of Research is the UK's free service for finding trials near you; taking part in NHS trials costs nothing and expenses are often paid.

BioCentury writes analysis for people who make decisions about pipelines.

BioPharma Dive offers clean, free industry reporting and is good for deal and approval context.

Breast Cancer Now's nurses answer 0808 800 6000 free, and the charity runs free courses and peer support for people finishing breast cancer treatment in the UK.

The Breast Cancer Research Foundation's weekly blog explains new breast cancer research findings and drug approvals in plain terms for a general audience, and reports on the research the foundation funds. It is free, and it bridges the research literature and patient-facing news.

Britain's own survivor cohort, built on national registration rather than on hospital volunteers, which is why it can follow people for half a century and count deaths that nobody reported. Its central finding is that what kills survivors changes with time: recurrence early, second cancers and heart disease late.

Find a mouse or dish model that matches a tumour type or mutation.

Cancer Research UK's nurses answer questions on 0808 800 4040, free, on weekdays; the About Cancer pages and Cancer Chat forum are there the rest of the time.

Cancer Research UK's About Cancer pages give clear UK patient information, including NHS treatment pathways.

The Cancer Support Community runs a free helpline and dozens of local centres, including Gilda's Clubs, where anyone with cancer can join free groups and classes.

CancerCare's oncology social workers give free counselling and support groups by phone and online to anyone in the US affected by cancer.

CancerNetwork publishes daily practice-oriented news across solid and haematologic cancers.

cBioPortal lets you browse the mutations, copy number, and expression of tens of thousands of tumours without writing code.

In the US, women with low income and no or little insurance can get free or low-cost breast and cervical screening through a CDC-funded programme in every state.

CIViC is an open, Wikipedia-style database of what cancer mutations mean for treatment.

ClinicalTrials.gov is the master list of clinical trials. Every trial on this site links to its record.

Whether a genetic variant is thought to cause disease, according to the labs that have seen it.

The Colorectal Cancer Alliance is the largest US colorectal cancer patient organisation, focused on screening uptake from age 45, young-onset disease and connecting patients with biomarker-matched trials.

Corporate Angel Network flies cancer patients to distant treatment for free, in empty seats on company jets.

COSMIC, the Catalogue of Somatic Mutations in Cancer, is the largest curated catalogue of mutations found in tumours, run by the Wellcome Sanger Institute. It also holds the Cancer Gene Census of around 750 genes, the reference mutational signatures and a cell line project; academic use is free, industry needs a licence.

CPTAC measures the proteins, not just the genes, of thousands of tumours.

CSCO guidelines are China's national oncology guidelines, covering about 30 cancers and updated annually. They grade each recommendation by both evidence level and affordability under China's reimbursement list, and they cover Chinese-developed drugs (PD-1 inhibitors, ADCs) and cancers common in China (nasopharyngeal, oesophageal, liver, gastric) years before Western guidelines.

CELLxGENE and the Human Cell Atlas hold single-cell data from healthy and diseased tissue, browsable and downloadable.

Which genes each cancer cell line cannot live without. The map of synthetic-lethal targets.

Dimensions connects papers to the grants and trials behind them.

DrugBank and ChEMBL hold the chemistry and mechanism of every drug and most tool compounds.

The EMA's CHMP highlights show Europe's approval pipeline one month ahead of European Commission decisions.

Endpoints News is the fastest read on what biotech and pharma are doing in oncology, deal by deal.

The ESMO guidelines are Europe's treatment algorithms, and the ESMO-MCBS scores how much each new drug actually helps.

ESMO Congress, held each October by the European Society for Medical Oncology, is Europe's largest oncology meeting and the autumn counterpart to ASCO, where phase 3 trials now regularly report for the first time. Abstracts are free in Annals of Oncology; other content is for registrants.

The EU Clinical Trials Register and CTIS are Europe's trial registry, complementing ClinicalTrials.gov for EU-only studies.

Evaluate Vantage forecasts which drugs and modalities will matter commercially in the next decade.

The FDA's oncology approval notifications are the official record of what is approved for what.

Fierce Biotech is where trial failures get reported plainly.

First Descents takes young adults with cancer on free week-long outdoor adventures, with the travel paid for too.

Real-world evidence at scale: what happened to patients with a given genomic profile on a given treatment.

FORCE gives free information, a helpline and peer navigators to anyone facing an inherited cancer risk such as a BRCA or Lynch syndrome gene change.

Gavi pays for HPV vaccine in lower-income countries so national programmes can give it to girls for free, where cervical cancer kills most.

GLOBOCAN is the world's cancer numbers: incidence and mortality estimates for 185 countries and 36 cancers.

Healio Hematology/Oncology publishes clinician-facing daily news with good approval and lifestyle-risk coverage.

The Human Protein Atlas shows where in the body each protein is found, which tells you whether an ADC target is safe.

Imerman Angels matches you free with someone who has been through the same cancer, so you can talk to a person who understands.

Three countries wrote three different sets of follow-up rules for the same survivors, and the rules disagreed about who to screen, how and how often. Since 2010 this group has been settling those disagreements one organ at a time, in public, with the evidence graded and the disagreement named.

IntOGen reads the mutations in thousands of tumour genomes and asks which genes are hit more often, or in more telling patterns, than chance allows. Those are its driver genes, and it says for each whether the mutations switch the gene on or knock it out.

In Ireland, BowelScreen, BreastCheck and CervicalCheck are free. You register once and get invited by age.

The JSMO and JSCO guidelines are Japan's oncology guidelines, especially strong for gastric, oesophageal, liver and biliary cancers where Japanese trials set global standards (D2 gastrectomy, S-1, endoscopic resection), and for Japan's own approvals through PMDA.

Kesem runs free summer camps for children whose mum or dad has cancer, staffed by college student volunteers across the US.

Knitted Knockers posts free soft knitted breast prostheses to anyone who has had breast surgery, made by volunteer knitters.

In Germany, the DKFZ's Krebsinformationsdienst answers questions about cancer free on 0800 420 30 40, every day, staffed by doctors.

Lazarex pays the travel and lodging costs that stop people joining cancer trials in the US, and helps them find a trial in the first place.

The Leukemia & Lymphoma Society is the main US blood-cancer charity, unusual for running its own precision-medicine trials (Beat AML, PedAL) and investing directly in biotech, alongside co-pay assistance and one-to-one information specialists.

LIVESTRONG at the YMCA is a free twelve-week exercise programme for adults who have had cancer, run at YMCAs across the US.

Congress results translated for people with breast cancer, fast and accurately.

Look Good Feel Better runs free workshops that teach people having cancer treatment how to manage skin, brow and hair changes, with a free product kit.

LUNGevity is the largest US lung cancer charity, focused on making sure every patient gets comprehensive biomarker testing and access to targeted therapy and trials, with a screening-advocacy partner in GO2.

The Lymphoma Research Foundation is the largest US lymphoma-specific charity, with plain-language guides for over 20 lymphoma subtypes and a research programme focused on mantle cell and adolescent/young adult lymphoma.

Macmillan Cancer Support covers the practical side of cancer: money, work, coping, and where to get help.

Macmillan's free line, 0808 808 00 00, puts you through to a nurse, a benefits adviser or a money adviser, seven days a week.

Maggie's centres sit next to NHS cancer hospitals and anyone can walk in, free, for support, benefits advice or a cup of tea.

Medscape Oncology publishes broad clinician news with continuing-education tie-ins.

A melanoma research funder created in 2007 by the Milken family that backed early immunotherapy and targeted-therapy work and now focuses on rare melanoma subtypes and resistance.

The Multiple Myeloma Research Foundation, founded by a patient in 1998, built CoMMpass, the largest open longitudinal genomic dataset in myeloma with 1,143 patients followed for over eight years, and helped fund early trials of bortezomib, lenalidomide, daratumumab and CAR-T. It also runs patient navigation and an immunotherapy hub.

The National Brain Tumor Society is the largest US brain tumour nonprofit. It co-founded GBM AGILE, the adaptive platform trial that has enrolled more than 1,500 glioblastoma patients across several drug arms at once, funds research collaboratives, and lobbies the FDA on endpoints for brain tumours.

Nature Briefing: Cancer is one email a week that catches the papers you missed.

The Nature Index shows which institutions publish the most top-tier research. It is the best public proxy for university output in cancer science.

The algorithms US oncologists follow. If a drug is in NCCN, insurers usually pay.

Call 1-800-4-CANCER and a trained NCI specialist answers your questions about any cancer, free, in English or Spanish.

NCI CDAS holds the lung screening trial images that trained Sybil and most lung-nodule AI.

The Imaging Data Commons is TCIA in the cloud, ready for large-scale model training.

The NCI's PDQ summaries are the most reliable free, plain-language explanation of each cancer's treatment.

NCI-designated cancer centres are the US government's list of the cancer centres that meet its research and care standards.

The Newsweek/Statista ranking is the most-cited global hospital ranking for cancer care. OnCo uses it as one input to its institution table.

In the UK the NHS invites you to bowel, breast and cervical screening by age, free, and is rolling out lung screening for people who smoke or used to.

In England, tumour and inherited cancer gene testing is free on the NHS when the National Genomic Test Directory lists it for your cancer. Your hospital team orders it.

If you are on certain benefits or a low income in England, the NHS refunds your travel costs to hospital appointments, including cancer treatment.

The NHS gives the HPV vaccine free at school around age 12 to 13, and anyone who missed it can still get it free until they turn 25.

Anyone in England with a Jewish grandparent can order a free NHS saliva test for BRCA gene changes, which raise breast, ovarian, prostate and pancreatic cancer risk.

NICE decides which cancer treatments the NHS pays for, publishing for each drug an appraisal of cost per quality-adjusted life year against a threshold of £25,000 to £35,000, plus clinical guidelines. Because the manufacturer models and committee reasoning are public, its decisions serve as an independent view of a drug's value that often diverges from FDA and EMA licensing.

NICE technology appraisals say whether the NHS will pay, and why. They are the most transparent HTA record in the world.

npj Precision Oncology is a Nature Portfolio journal that publishes genomics, artificial intelligence and biomarker studies continuously rather than in issues. Every article is open access under a CC BY licence, so it can be read in full without a subscription.

OncLive, run by MJH Life Sciences, publishes daily oncology news, approval alerts and video interviews with trial investigators, often within hours of a readout. Industry-sponsored content is common, so check numbers against the primary source before relying on them.

OncoDaily publishes a high volume of daily oncology news, education and career items from outside the United States, which is the perspective US-centred feeds lack. It is free, but trial news is mixed with profiles and history pieces, so check primary sources before reusing a figure.